Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...
Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...
Early-stage lung adenocarcinoma alters DNA methylation, mRNA transcription, and protein expression in adjacent tissues, exhibiting either steep changes at the tumor boundaries or shallow changes ...
Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Chemotaxis receptors typically mediate biased ...
Abstract: Single-cell RNA sequencing (scRNA-seq) technology offers unprecedented opportunities for inferring gene regulatory networks (GRNs) at the genome level. However, scRNA-seq data is highly ...
ATG-022 is a CLDN18.2-targeted ADC with sub-nM affinity and fast internalization. Using a VC-MMAE linker-payload (DAR 4), ATG-022 has demonstrated potent activity across tumors with high, low, and ...
October 15, 2025- (Investorideas.com Newswire), a go-to investing platform covering biotech and medtech stocks releases a news and trading alert for Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene ...
AUSTIN, Texas, Oct. 14, 2025 /PRNewswire/ -- Genprex, Inc. (GNPX) ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for ...
Each year, a small number of babies are born mostly, if not fully, deaf because one of their genes isn’t working. The gene normally makes a protein that the hairs in our inner ears need to relay sound ...
I don’t use Microsoft Excel all that often, so it remains a bit of a mystery to me. I can enter text and create graphs and that’s basically it. That’s why I’ve set myself a goal to learn one new Excel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback